Tudor Investment Corp Et Al

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
1,906
Total Value
9382651729
Accession Number
0000902664-25-002382
Form Type
13F-HR
CIK
0000923093
Manager Name
Tudor Investment Corp Et Al
Data Enrichment
93% identified
1,782 identified124 unidentified

Holdings

1,906 positions
Manager:
SEC
Search and click to pin securities to the top
Page 94 of 96
Prime Medicine, Inc.
PRME|74168J101
Shares:
60368
Value:
$120.1M
CONSTELLIUM SE
CSTM|F21107101
Shares:
11800(-15.7%)
Value:
$119.1M(-17.2%)
Amylyx Pharmaceuticals, Inc.
AMLX|03237H101
Shares:
33428(-0.8%)
Value:
$118.3M(-7.1%)
Warner Bros. Discovery, Inc.
WBD|934423104
Shares:
10800(-98.8%)
Value:
$115.9M(-98.8%)
Village Farms International, Inc.
VFF|92707Y108
Shares:
189300(+0.0%)
Value:
$114.5M(-21.5%)
Senseonics Holdings, Inc.
SENS|81727U105
Shares:
174383(+0.0%)
Value:
$114.4M(+25.4%)
Purple Innovation, Inc.
PRPL|74640Y106
Shares:
150649(+0.0%)
Value:
$114.4M(-2.7%)
Tyra Biosciences, Inc.
TYRA|90240B106
Shares:
12093(-22.4%)
Value:
$112.5M(-48.0%)
Elanco Animal Health Inc
ELAN|28414H103
Shares:
10200
Value:
$107.1M
Western Union CO
WU|959802109
Shares:
10100(-98.5%)
Value:
$106.9M(-98.5%)
PRECIGEN, INC.
PGEN|74017N105
Shares:
71464(+0.0%)
Value:
$106.5M(+33.0%)
IAMGOLD CORP
IAG|450913108
Shares:
17011(-10.4%)
Value:
$106.3M(+8.5%)
iTeos Therapeutics, Inc.
ITOS|46565G104
Shares:
17651
Value:
$105.4M
Allogene Therapeutics, Inc.
ALLO|019770106
Shares:
71008
Value:
$103.7M
Cushman & Wakefield plc
CWK|G2717B108
Shares:
10000(-95.7%)
Value:
$102.2M(-96.7%)
Open Lending Corp
LPRO|68373J104
Shares:
35607
Value:
$98.3M
Bloomin' Brands, Inc.
BLMN|094235108
Shares:
12900(-41.1%)
Value:
$92.5M(-65.4%)
PLAYSTUDIOS, Inc.
MYPS|72815G108
Shares:
70871(-0.3%)
Value:
$90.0M(-31.9%)
4D Molecular Therapeutics, Inc.
FDMT|35104E100
Shares:
25399(-7.4%)
Value:
$82.0M(-46.3%)
ImmunityBio, Inc.
IBRX|45256X103
Shares:
24253
Value:
$73.0M